Clinical Presentation and Potential Complications
The disease is characterized by prominent systemic involvement. Primarily, clinical symptoms strongly resemble typical viral or mycoplasmal pneumonia. However, the infectious process is not limited to the respiratory system: the liver, kidneys, adrenal glands, and joints are actively involved in the pathological process.
Modern medicine also distinguishes a specific form—generalized zoonotic chlamydiosis. In this case, transmission occurs directly from infected mammals.
The acute phase of the disease lasts on average about one month. There is always a risk that the infection will transition into a chronic stage. In most cases, with timely and appropriate therapy, the prognosis remains favorable. Nevertheless, mortality rates are not entirely excluded, ranging around 2–3%.
Failure to provide prompt treatment can lead to severe complications. Pathologies of the central nervous system, such as meningitis or meningoencephalitis, frequently develop. The cardiovascular system is also targeted: the pathogen is capable of causing inflammation of the heart membranes—myocarditis, endocarditis, and pericarditis.
Features of the Immune Response
Following the disease, cell-mediated and humoral immunity is formed. Its main feature is that it is non-sterile (infectious). This means that defensive mechanisms remain active only as long as the pathogen physically persists within the patient's body.
The established immune protection is characterized by very low avidity and extremely short duration. Consequently, patients remain vulnerable to recurrent infections: reinfection is quite possible as early as six months to two years after the initial episode.
A hallmark of the pathogen is prolonged persistence within host cells. This long-term survival of the pathogen in internal organs is the primary cause of frequent clinical relapses, even if the initial acute phase was successfully resolved.
Microbiological Diagnosis
Proper laboratory diagnosis requires selecting appropriate biological samples based on the stage of the disease. In the first days of the illness, the patient's blood is examined. Sputum is suitable for analysis throughout the acute phase, and blood serum is collected for serological assays. A critical step during epidemiological history taking is identifying any history of contact with birds or animals.
Three main approaches are used in laboratory practice:
- Serological method (primary). Considered the most informative and safest for medical personnel. Assays such as complement fixation test (CFT), ELISA, and micro-immunofluorescence are utilized. The core principle is testing "paired sera." The first blood sample is drawn at the onset of the disease, and the second is taken 7–10 days later. Diagnosis is confirmed by detecting high titers of IgM antibodies or a reliable 4-fold rise in titer in the second serum sample.
- Biological (culture) method. Involves inoculation of chicken embryos (into the yolk sac), laboratory white mice, or specialized cell lines. In practice, this approach is rarely used due to the exceptionally high risk of laboratory-acquired infection.
- Allergic method. Based on detecting delayed-type hypersensitivity (DTH). This involves performing an intradermal skin test with a specific allergen—ornithin.
Treatment and Prevention
Etiotropic treatment of psittacosis is based on antibacterial drugs. Antibiotics belonging to the tetracycline and macrolide groups are the drugs of choice.
Regarding disease prevention, specific prophylaxis (vaccination) is currently unavailable. All measures are exclusively non-specific and aimed at eliminating transmission risks.
Key measures include:
- Strict sanitary and veterinary control at poultry farming facilities.
- Regulation of urban bird populations, primarily pigeons.
- Thorough adherence to personal hygiene rules.
- Mandatory thermal processing of poultry meat before consumption.
- Conducting sanitary and educational awareness among the public.